Job Title:
Associate Delivery Analysts (Content Editor - Life Science
Company: Infodesk
Location: Kolhapur, Maharashtra
Created: 2025-12-06
Job Type: Full Time
Job Description:
Remote Position - Full Time - Morning Shift - Salary + Benefits +Internet Reimbursement InfoDesk has a need for life sciences delivery analysts to help meet the custom information needs of a high-profile, global clientele of pharmaceutical and biotech companies. The role includes curating aggregated news to build compelling reports, constructing Boolean profiles, researching timely topic matter, peer reviewing curated reports, and assisting with quality assurance. A comfort level with pharmaceutical content such as clinical trials, compounds, indications, and related subject matter is important to our collective success. Scope of Work:Attention to detail involving relevance, grammar, context and instructions.Adhere to journalistic standards of objectivity, fairness, accuracy and thoroughness.Responsible for current awareness or media monitoring based on custom scope instructions.Communicate challenges or obstacles with clear and regular communication.Work under deadlines and take responsibility for consistent, high-quality assignments.Adapt to various search methods and tools whether online or with proprietary tools.Analytical and creative problem-solving skills.Curation of Life Sciences projects involving compounds, indications, drug pipelines and R&D, or regulatory affairs impacting a broad array of related interests.RequirementsAdept communication skills.3-5 years’ content production &/or editorial experience.Reliable remote infrastructure (electricity, fixed broadband, controlled space free of distraction).Bachelor’s degree.Ability to work independently, confidently, and remotely each day.Comfort using common software/apps (i.e. Microsoft Office, publishing tools).PreferredWorking experience in the Pharmaceuticals or Biotech industries.Familiarity with reliable sources covering the pharmaceutical and life sciences industries.An understanding of the Pharmaceutical regulatory landscape would be particularly advantageous.